Option chain shows key data for Bayer's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Bayer.

Bayer (OTC:BAYRY) Stock, Option Chain

BAYER AKTIENGES ADS

Bayer

Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm's crop science business sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.

Basel,,Switzerland,-,April,20,,2024:,Bayer,Ag,Is,A

Biotech

Earnings

Large Cap

News

Guidance

Health Care

Movers

Trading Ideas

General

BAYRY

Bayer reported Q4 adjusted EPS of $0.28, missing estimates, but sales beat forecasts. The company sees 2025 as a tough year, with growth expected from 2026.

Bayer CEO: 2025 Will Be &#39;Most Difficult&#39; Year In Turnaround Plan, Expects Improved Performance From 2026 Onwards

Screenshot 2025-02-04 at 6.43.58 PM

RDHL

New Prostate Cancer Hope? Bayer-Funded Phase 2 Study To Test Combination Of RedHill&#39;s Opaganib And Bayer&#39;s Darolutamide, To Overcome Androgen Resistance

Trauma To The Eye

REGN

Regeneron&#39;s EYLEA HD met key goals in the Phase 3 QUASAR trial for macular edema after retinal vein occlusion, with FDA submission expected in Q1 2025.

Regeneron&#39;s Best-Selling Eye Drug Eylea&#39;s Higher Dose Formulation Meets Primary Goal In Another Form Of Retinal Disease Study

Bayer AG

Press Releases

"Signing Day Sports, Inc. (NYSE American: SGN) Soars in Pre-Market on Acquisition News – see more penny stocks inside…."

Comments

Bayer

Bayer (BAYRY) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga